ErbB 2 Rabbit Monoclonal Antibody

ErbB 2 Rabbit Monoclonal Antibody

Cat: AMRe86308
Size1:50μL Price1:$188
Size2:100μL Price2:$338
Application:WB, IHC-P, ICC/IF, FC, IP

Reactivity:Human,Mouse,Rat
Conjugate:Unconjugated
Optional conjugates: Biotin, FITC (free of charge).
See other 26 conjugates.

Gene Name:ErbB 2
Category: Recombinant Monoclonal Antibody Tags: , , , , , , , , ,

Summary

Production Name

ErbB 2 Rabbit Monoclonal Antibody

Description

Rabbit Monoclonal antibody

Host

Rabbit

Application

WB, IHC-P, ICC/IF, FC, IP

Reactivity

Human,Mouse,Rat

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

IgG

Clonality

Monoclonal Antibody

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% protective protein . Stable for 12 months from date of receipt.

Purification

Affinity Purification

 

Immunogen

Gene Name

ErbB 2

Alternative Names

NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu

Gene ID

2064

SwissProt ID

P04626

 

Application

Dilution Ratio

WB: 1:1000 IHC-P: 1:500-1:2000 ICC/IF: 1:100-1:200 FC: 1:50-1:100 IP: 1:20-1:50

Molecular Weight

Calculated MW:138 kDa; Observed MW:185 kDa

 

Background

This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]

 

Research Area

Cancer